Neuromyelitis optica spectrum disorder diagnostic criteria: Sensitivity and specificity are both important

Abstract

Get full access to this article

View all access options for this article.

References

Lennon

Wingerchuk

Kryzer

. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106–2112.

Wingerchuk

Lennon

Pittock

. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485–1489.

Wingerchuk

Lennon

Lucchinetti

. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 810–815.

Wingerchuk

Banwell

Bennett

. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015; 85: 177–189.

Hamid

SHM

Elsone

Mutch

. The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates. Mult Scler. Epub ahead of print 23 August 2016. DOI: 10.1177/1352458516663853.

Hyun

Jeong

Joung

. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder. Neurology 2016; 86: 1772–1779.

Aggarwal

Ringold

Khanna

. Distinctions between diagnostic and classification criteria. Arthritis Care Res 2015; 67: 891–897.

Zekeridou

Lennon

. Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm 2015; 2(4): e110.

Sepúlveda

Armangué

Sola-Valls

. Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 2016; 3: e225.

10.

Jurynczyk

Weinshenker

Akman-Demir

. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. J Neurol 2016; 263: 140–149.

11.

Kaneko

Sato

Nakashima

. Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies. J Neurol Neurosurg Psychiatry 2016; 87: 1257–1259.

12.

Popescu

Guo

Jentoft

. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions. Neurology 2015; 84: 148–158.